Imatinib Mesylate in Treating Patients With Refractory Metastatic and/or Unresectable Stomach or Gastroesophageal Junction Cancer

This study has been completed.

Study NCT00068380 Information provided by California Cancer Consortium

First Received: September 10, 2003 Last Updated: October 11, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)